Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Healius Limited ( (AU:HLS) ) is now available.
Healius Limited announced the cessation of 616,606 performance rights due to the lapse of conditional rights that were not met. This announcement may impact the company’s capital structure and could have implications for stakeholders regarding the company’s performance metrics and future financial planning.
The most recent analyst rating on (AU:HLS) stock is a Hold with a A$0.87 price target. To see the full list of analyst forecasts on Healius Limited stock, see the AU:HLS Stock Forecast page.
More about Healius Limited
Healius Limited operates in the healthcare industry, providing medical and diagnostic services. The company focuses on delivering healthcare solutions and services across Australia.
Average Trading Volume: 6,550,552
Technical Sentiment Signal: Sell
Current Market Cap: A$617.2M
See more insights into HLS stock on TipRanks’ Stock Analysis page.